Table 2 Mean and 95% confidence interval for clinically relevant variables at baseline and after intervention in patients with type 2 diabetes mellitus (n = 498)

 Glycemic control (HbA1c1, %)

9.48

(9.285, 9.666)

6.83

(6.720, 6.935)

<  0.001

  Systolic

128.79

(127.034–130.552)

119.11

(117.735, 120.488)

<  0.001

  Diastolic

74.21

(73.355, 75.070)

70.99

(70.196, 71.780)

0.003

 LDL-Cholesterol (mg/dL)

111.10

(107.667, 114.528)

92.89

(89.976, 95.803)

<  0.001

Diabetes knowledge

3.06

(2.848, 3.265)

8.06

(7.901, 8.223)

<  0.001

 Specific

2.92

(2.764, 3.067)

4.39

(4.236, 4.539)

<  0.001

 Global

2.46

(2.278, 2.648)

5.71

(5.575, 5.838)

<  0.001

 Total

2.69

(2.549, 2.829)

5.05

(4.933, 5.162)

<  0.001

Physical activity

1.85

(1.650, 2.051)

4.09

(3.897, 4.290)

<  0.001

Glucometer

1.66

(1.456, 1.854)

4.01

(3.840, 4.176)

<  0.001

Foot care

3.52

(3.245, 3.791)

6.63

(6.527, 6.728)

<  0.001

Self-care global score^a

2.42

(2.287, 2.559)

4.92

(4.828, 5.017)

<  0.001

 Weight (kg)

73.19

(71.783, 74.590)

71.56

(70.215, 72.905)

<  0.001

 BMI (kg/m²)

30.24

(29.693, 30.797)

29.57

(29.048, 30.092)

<  0.001

 Quality of life by VAS

60.61

(58.583, 62.633)

86.97

(85.935, 88.008)

<  0.001

n

%

n

%

 Glycemic control (HbA1c1, %)

64

12.85%

313

62.85%

<  0.001

  Systolic

287

57.63%

362

73.43%

<  0.001

  Diastolic

363

72.89%

394

80.08%

0.009

 LDL-Cholesterol (mg/dL)

160

39.41%

281

65.50%

<  0.001

 Triple target

9

1.81%

129

25.90%

<  0.001